Ment 50 mg

Ment 50 mg contains trestolone acetate, an investigational compound that was studied as a male contraceptive but never marketed for medical use. In non-medical bodybuilding settings, Ment 50 mg is commonly referenced for rapid muscle and strength gains due to its high anabolic potency, though such use falls outside any approved medical indication.

Because of its short acetate ester and approximately 24-hour half-life, trestolone acetate is typically referenced as being administered daily or every other day in non-medical contexts. Some users prefer splitting daily doses into morning and evening injections to reduce estrogen spikes.

In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a trestolone cycle to help restore endogenous testosterone production. Because of the short acetate ester, PCT can typically begin 3–7 days after the final injection. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.

Trestolone acetate is a potent anabolic steroid derived from nandrolone that binds to the androgen receptor with high affinity and promotes nitrogen retention and protein synthesis. It does not convert to DHT due to 5α-reductase resistance, but it is a potent aromatase substrate that converts to 7α-methylestradiol, a highly potent estrogen.

Because of its short acetate ester, trestolone acetate reaches stable blood levels relatively quickly. In non-medical contexts, users commonly reference noticing rapid increases in strength and muscle fullness within the first week of use. The potent estrogenic effects may also become apparent quickly, requiring proactive management.

There is no single compound that is universally best for bulking. Trestolone is commonly referenced in bodybuilding contexts for its exceptional potency and rapid effects. However, its potent estrogenic activity requires careful management with aromatase inhibitors and other support compounds. Other products such as Deca 300 and Cypionate 250 are also referenced for bulking purposes.

The primary difference is the ester and concentration. Ment 50 mg contains trestolone acetate at 50 mg/mL, which is a short-acting ester requiring frequent injections. Trestolone 100 contains trestolone enanthate at 100 mg/mL, which is a longer-acting ester requiring less frequent injections. Both ultimately provide the same parent hormone, trestolone.

Trestolone is significantly more potent than testosterone, with an anabolic-to-androgenic ratio of approximately 600:200 compared to testosterone's 100:100. Unlike testosterone, trestolone does not convert to DHT and does not bind to SHBG. However, it converts to a more potent estrogen (7α-methylestradiol) than testosterone does.

A milligram amount cannot be classified as appropriate or excessive without considering the specific context, individual response, and other factors. In non-medical bodybuilding contexts, trestolone acetate is commonly referenced in the 25–50 mg per day range for intermediate users. Such use falls outside approved indications and requires careful management of estrogenic side effects.

Ment 50 mg is labeled at 50 mg of trestolone acetate per mL. It is supplied in a 10 mL vial, giving 500 mg of total labeled trestolone acetate content per vial.

Yes. A published laboratory report dated March 21, 2024 measured Ment 50 mg at 51.36 mg, equivalent to 102.72% of its 50 mg/mL label claim.

The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.

Trestolone converts to 7α-methylestradiol through aromatization, which is a more potent estrogen than the estradiol produced from testosterone. This means that even at relatively low doses, trestolone can produce significant estrogenic effects such as gynecomastia and water retention. Management with aromatase inhibitors and possibly SERMs is commonly referenced in non-medical contexts.